Publications by authors named "Vincent Ribrag"

100Publications

Can Next-Generation PI3K Inhibitors Unlock the Full Potential of the Class in Patients With B-Cell Lymphoma?

Clin Lymphoma Myeloma Leuk 2020 Sep 18. Epub 2020 Sep 18.

Institut de Cancérologie Gustave Roussy, Villejuif, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2020.08.022DOI Listing
September 2020

Letter responds to the comment in 'immune thrombocytopenia of haematological immune-related adverse events in cancer immunotherapy: Most and mighty'.

Eur J Cancer 2020 07 26;134:60-61. Epub 2020 May 26.

Hôpitaux de Paris, Hôpital Bicêtre, Médecine Interne et Immunologie Clinique, F-94275, Le Kremlin-Bicêtre, France; INSERM U1184, Immunology of Viral Infections and Autoimmune Diseases, F-94276, Le Kremlin-Bicêtre, France; Université Paris Sud, UMR 1184, F-94276, Le Kremlin-Bicêtre, France; CEA, DSV/iMETI, IDMIT, F-92265, Fontenay-aux-Roses, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2020.03.012DOI Listing
July 2020

Novel agents for mantle cell lymphoma: molecular rational and clinical data.

Expert Opin Investig Drugs 2020 Jun 12;29(6):555-566. Epub 2020 May 12.

DITEP, Gustave Roussy Cancer Campus , Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/13543784.2020.1760245DOI Listing
June 2020

Burkitt and Burkitt-Like Lymphomas: a Systematic Review.

Curr Oncol Rep 2020 03 6;22(4):33. Epub 2020 Mar 6.

Département d'Hématologie, Institut de Cancérologie Gustave Roussy, 114 Rue Edouard Vaillant, 94810, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-020-0898-8DOI Listing
March 2020

Fatigue level changes with time in long-term Hodgkin and non-Hodgkin lymphoma survivors: a joint EORTC-LYSA cross-sectional study.

Health Qual Life Outcomes 2019 Jul 2;17(1):115. Epub 2019 Jul 2.

Centre de Traitement des Données du Cancéropôle Nord-Ouest, Plateforme de Recherche Clinique Ligue Contre le Cancer, Centre François Baclesse, 3 Avenue Général Harris, 14076, Caen, Cedex 5, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12955-019-1186-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6604328PMC
July 2019

Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study.

Lancet Haematol 2019 Jan 4;6(1):e48-e57. Epub 2018 Dec 4.

Service de Médecine Interne and Immunologie Clinique, Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris, Le Kremlin-Bicêtre, France; Université Paris Sud, Centre de Recherche en Immunologie des Infections Virales et des Maladies Auto-Immunes, INSERM, Le Kremlin-Bicêtre, France; Division d'Immunovirologie, Commissariat à l'Energie Atomique et aux Energies Alternatives, Fontenay-aux-Roses, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(18)30175-3DOI Listing
January 2019

Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma.

N Engl J Med 2018 09;379(10):934-947

From Université Lille, Centre Hospitalier Universitaire (CHU), Groupe de Recherche sur les formes Injectables et les Technologies Associées, Lille (F.M.), CHU Régional de Nancy, Service d'Hématologie, Vandoeuvre lès Nancy (P.F.), Institut Paoli-Calmettes (R.B.) and Department of Pathology, Institut Paoli-Calmettes, Centre de Recherche en Cancerologie de Marseille, INSERM, Centre National de la Recherche Scientifique, Aix-Marseille Université (L.X.), Marseille, Centre Henri Becquerel, Unité 1245 and Département d'Hématologie, Université de Rouen, Rouen (H.T.), Institut d'Hématologie de Basse Normandie, Caen (C.F.), CHU Le Bocage Service d'Hématologie Clinique, Dijon (R.-O.C.), Hôpital Henri Mondor Unité Hémopathies Lymphoïdes, Créteil (C.H.), Centre Hospitalier Départemental Vendée Service d'Onco-Hématologie, La Roche sur Yon (H.M.), Institut Universitaire du Cancer de Toulouse Oncopole Service d'Hématologie, Toulouse (L.Y.), CHU Bordeaux, Service d'Hématologie, Bordeaux (K.B.), Hôpital Saint Louis Service d'Onco-Hématologie, Paris (P.B.), Gustave Roussy Cancer, Villejuif (V.R.), Centre Hospitalier Annecy Genevois Service, Annecy (N.D.), CHU de Nantes-Hôtel Dieu Service d'Hématologie Clinique, Centre de Recherche en Cancerologie et Immunologie, INSERM, Centre National de la Recherche Scientifique, Université de Nantes, Nantes (S.L.G.), Centre Hospitalier Métropole Savoie Service Hématologie, Chambery (G.M.P.), Department of Hematology, CHU Montpellier, University of Montpellier, Montpellier (G.C.), and Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, University of Lyon, Pierre-Benite (G.A.S.) - all in France; the Department of Lymphoma and Myeloma, University of Texas M.D. Anderson Cancer Center, Houston (N.H.F.); the Department of Medicine, Memorial Sloan Kettering Cancer Center, New York (M.L.P.); the Department of Medicine, Division of Medical Oncology, University of Washington, Seattle (E.N.L.); Sarah Cannon Research Institute-Tennessee Oncology, Nashville (I.W.F.); Washington University School of Medicine, Siteman Cancer Center, St. Louis (N.L.B.); the Department of Hematology, Hospital Universitario de Salamanca and Instituto de Investigación Biomédica de Salamanca, Centro de Investigación Biomédica en Red de Cáncer, Salamanca (A.M.G.-S.), and the Department of Hematology, Hospital Clinic de Barcelona, Barcelona (A.L.-G.) - both in Spain; CHU de Québec, Hôpital de l'Enfant-Jésus, Quebec (J.-F.L.), and British Columbia Cancer Centre for Lymphoid Cancer, University of British Columbia, Vancouver (L.H.S.) - both in Canada; the Department of Hematology and Oncology, Tokai University Hospital, Kanagawa, Japan (K.A.); Instituto Português de Oncologia Lisboa Francisco Gentil Departamento de Hematologia, Lisbon (M.G.S.); the Department of Hematology, CHU Université Catholique de Louvain Namur, Yvoir (M.A.), and the Department of Hematology, Ziekenhuis Netwerk Antwerpen Stuivenberg, Antwerp (P.Z.) - both in Belgium; the Department of Hematology, National Cancer Center Hospital, Tokyo, Japan (K.T.); and Celgene, Summit, NJ (D.L., J.W.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1805104
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1805104DOI Listing
September 2018

Vemurafenib in Patients With Relapsed Refractory Multiple Myeloma Harboring Mutations: A Cohort of the Histology-Independent VE-BASKET Study.

JCO Precis Oncol 2018 31;2. Epub 2018 Aug 31.

and Massachusetts General Hospital, Boston, MA; and Royal Marsden Hospital, Sutton, Surrey, United Kingdom; and Memorial Sloan Kettering Cancer Center, New York; Roswell Park Cancer Institute, Buffalo, NY; and Institut Gustave Roussy, Villejuif; Centre Leon-Berard, Lyon, France; and , Vall d'Hebron University Hospital and Institute of Oncology, Universitat Autònoma de Barcelona, Barcelona, Spain; University Hospital Köln, Köln, Germany; and F. Hoffmann-La Roche Ltd, Basel, Switzerland; and F. Hoffmann-La Roche Ltd, Mississauga, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/PO.18.00070DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446434PMC
August 2018

Kinetics and nadir of responses to immune checkpoint blockade by anti-PD1 in patients with classical Hodgkin lymphoma.

Eur J Cancer 2018 03;91:136-144

Department of Medicine Oncology, Gustave Roussy Comprehensive Cancer Center, F-94805 Villejuif, France; Gustave Roussy, Université Paris-Saclay, Département D'hématologie, Villejuif F-94805, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.12.015DOI Listing
March 2018

[Hodgkin lymphoma: Current and future therapeutic strategies].

Bull Cancer 2018 Jan 27;105(1):81-98. Epub 2017 Dec 27.

Cancer campus Grand-Paris, Gustave-Roussy cancer comprehensive center, département d'hématologie, 114, rue Édouard-Vaillant, 94805 Villejuif, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2017.11.008DOI Listing
January 2018

Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma.

N Engl J Med 2017 09;377(13):1250-1260

From Service d'Hématologie Clinique (S.L.G., T.G.), Service d'Anatomopathologie (A.M.), and Service d'Hématologie Biologique (M.C.B.), Hôtel-Dieu Centre Hospitalier Universitaire (CHU) de Nantes, and Centre de Recherche en Cancérologie et Immunologie (S.L.G., M.C.B.) and Faculté de Médecine (S.L.G.), Université de Nantes, Nantes, Hemato-Oncologie, Assistance Publique-Hôpitaux de Paris (APHP), Hôpital Saint-Louis, Université Diderot Sorbonne Paris-Cité (C.T.), Université Descartes (C.T.), Département d'Hématologie, Faculté de Médecine, Université Paris-Sud (V.R.), Département d'Anatomopathologie (D.C.) and Département d'Hématologie (O.H.), Necker Hospital, APHP, Sorbonne Paris-Cité, and INSERM Unité 1163 et Centre National de la Recherche Scientifique (CNRS) Équipe de Recherche Labellisée 8654, Imagine Institute (O.H.), Paris, Département d'Hématologie, Institut Universitaire du Cancer-Oncopole de Toulouse, Toulouse (L.O.), Service d'Hématologie Clinique et Thérapie Cellulaire, CHU de Bordeaux, Bordeaux (K.B.), Service d'Hématologie et Thérapie Cellulaire, CHU de Tours, Tours (C.D.), Service d'Hématologie, CHU d'Amiens, Amiens (G.D.), INSERM, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif (V.R.), Département d'Hématologie, CHU de Nancy, Nancy (P.F.), INSERM Unité 954, Vandoeuvre (P.F.), Service d'Hématologie Clinique, CHU de Dijon, and INSERM Unité Mixte de Recherche 1231, Dijon (O.C.), Service d'Hématologie, Centre Hospitalier d'Avignon, Avignon (H.Z.), Lymphoid Malignancies Unit, Hôpital Henri Mondor, APHP, Créteil (C.H.), Service d'Hématologie du Centre Hospitalier de Vendée, La Roche-sur-Yon (H.M.), Service Hématologie Clinique (R.H.) and Département d'Hématologie (T.L.), CHU de Rennes, INSERM Unité 917 (R.H.), and INSERM Unité 1236 (T.L.), Rennes, Département d'Hematology, Centre Henri-Becquerel et Université de Normandie Unité 1245, Rouen (F.J., H.T.), Service d'Hématologie Clinique Adulte et de Thérapie Cellulaire, CHU de Clermont-Ferrand et Université Clermont Auvergne, Clermont-Ferrand (O.T.), Service d'Hématologie, Clinique Victor Hugo, Le Mans (K.L.D.), Department of Hematology, Université de Lille, Groupe de Recherche sur les Formes Injectables et les Technologies Associées, and CHU de Lille, Lille (F.M.), Département d'Hématologie Clinique, CHU de Montpellier, CNRS UMR 5235, Montpellier (G.C.), Service d'Oncologie et d'Hématologie, Hôpitaux Universitaires de Strasbourg, Strasbourg (L.-M.F.), INSERM 1209, CNRS UMR 5309, Faculté de Médecine, Université Grenoble Alpes (M.C., R.G.), Institute for Advanced Biosciences (M.C.), and Laboratoire de Génétique Onco-hématologie (M.C.) and Faculté de Médecine (R.G.), CHU de Grenoble Alpes, Grenoble, Service d'Hématologie, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre-Bénite (G.S.), and Université Claude Bernard Lyon 1 and Cancer Research Center of Lyon, INSERM 1052 CNRS 5286 Lyon, Lyon (G.S.) - all in France; and Département d'Hématologie, Cliniques Universitaires Saint-Luc-Université Catholique de Louvain, Brussels (E.V.D.N.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1701769DOI Listing
September 2017

Challenges and perspectives in the immunotherapy of Hodgkin lymphoma.

Eur J Cancer 2017 11 9;85:67-77. Epub 2017 Sep 9.

Département des Innovations Thérapeutiques et des Essais Précoces, Gustave Roussy, 114 Rue Edouard-Vaillant, F-94805 Villejuif, France; Département d'Oncologie Médicale, Institut Jules Bordet, rue Héger Bordet 1, B-1000 Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.08.014DOI Listing
November 2017

Poor predictive value of positive interim FDG-PET/CT in primary mediastinal large B-cell lymphoma.

Eur J Nucl Med Mol Imaging 2017 Nov 21;44(12):2018-2024. Epub 2017 Jun 21.

Department of Hematology, Gustave Roussy and Université Paris Saclay, 114 Rue Edouard Vaillant, 94805, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-017-3758-5DOI Listing
November 2017

Immune-related bone marrow failure following anti-PD1 therapy.

Eur J Cancer 2017 07 17;80:1-4. Epub 2017 May 17.

Assistance Publique - Hôpitaux de Paris, Hôpital Bicêtre, Service de Médecine Interne et Immunologie clinique, F-94275 Le Kremlin-Bicêtre, France; Université Paris Sud, UMR 1184, F-94276 Le Kremlin-Bicêtre, France; CEA, DSV/iMETI, IDMIT, F-92265 Fontenay-aux-Roses, France; INSERM, U1184, Immunology of Viral Infections and Autoimmune Diseases, F-94276 Le Kremlin-Bicêtre, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.04.004DOI Listing
July 2017

Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma.

J Clin Oncol 2017 Jul 25;35(19):2125-2132. Epub 2017 Apr 25.

Robert Chen, City of Hope National Medical Center, Duarte, CA; Pier Luigi Zinzani, University of Bologna, Bologna, Italy; Michelle A. Fanale, The University of Texas MD Anderson Cancer Center, Houston, TX; Philippe Armand and Margaret A. Shipp, Dana-Farber Cancer Institute, Boston, MA; Nathalie A. Johnson, Jewish General Hospital, Montreal, Canada; Pauline Brice, Hôpital Saint-Louis, Paris; Vincent Ribrag, Institut Gustave Roussy, Villejuif, France; John Radford, The University of Manchester and Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom; Daniel Molin, Uppsala University, Uppsala, Sweden; Theodoros P. Vassilakopoulos, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece; Akihiro Tomita, Nagoya University Graduate School of Medicine, Nagoya, Japan; Bastian von Tresckow, University Hospital Cologne, Cologne, Germany; Yinghua Zhang, Alejandro D. Ricart, and Arun Balakumaran, Merck, Kenilworth, NJ; Craig H. Moskowitz, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.72.1316DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791843PMC
July 2017

Abscopal effect in a Hodgkin lymphoma patient treated by an anti-programmed death 1 antibody.

Eur J Cancer 2016 10 18;66:91-4. Epub 2016 Aug 18.

Drug Development Department, Gustave Roussy, Université Paris-Saclay, F-94805, Villejuif, France; Department of Radiation Oncology, Gustave Roussy, Université Paris-Saclay, F-94805, Villejuif, France; INSERM U1030, Molecular Radiotherapy, Gustave Roussy, Université Paris-Saclay, F-94805, Villejuif, France; Univ Paris Sud, Université Paris-Saclay, F-94270, Le Kremlin-Bicêtre, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2016.06.017DOI Listing
October 2016

Programmed Death-1 Blockade With Pembrolizumab in Patients With Classical Hodgkin Lymphoma After Brentuximab Vedotin Failure.

J Clin Oncol 2016 11;34(31):3733-3739

Philippe Armand and Margaret A. Shipp, Dana-Farber Cancer Institute, Boston, MA; Vincent Ribrag and Jean-Marie Michot, Institut Gustave Roussy, Villejuif, France; Pier Luigi Zinzani, Institute of Hematology Seràgnoli, University of Bologna, Bologna, Italy; John Kuruvilla, Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada; Ellen S. Snyder, Alejandro D. Ricart, Arun Balakumaran, and Shelonitda Rose, Merck, Kenilworth, NJ; and Craig H. Moskowitz, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.3467DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791838PMC
November 2016

Is distal motor and/or sensory demyelination a distinctive feature of anti-MAG neuropathy?

J Neurol 2016 Sep 17;263(9):1761-70. Epub 2016 Jun 17.

Service de Physiologie Clinique-Explorations Fonctionnelles, AP-HP, Hôpital Lariboisière, 2, rue Ambroise Paré, 75010, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00415-016-8187-zDOI Listing
September 2016

Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network.

J Clin Oncol 2016 Apr 29;34(12):1386-94. Epub 2016 Feb 29.

Eva Hoster, Roswitha Forstpointner, Christian Schmidt, Wolfgang Hiddemann, Michael Unterhalt, and Martin H. Dreyling, University Hospital Munich; Eva Hoster, University of Munich, Munich; Andreas Rosenwald, University of Würzburg, Würzburg; Heinz-Wolfram Bernd, University Hospital Schleswig-Holstein, Lübeck; Sylvia Hartmann, University Hospital of Frankfurt, Frankfurt am Main; Christoph Loddenkemper, University Hospital Berlin Charité; Christoph Loddenkemper, Pathologie PathoTres, Berlin; Thomas F.E. Barth, University Medical Center Ulm; Stephan Stilgenbauer, University of Ulm, Ulm; Michael Hallek, Universität zu Köln, Köln; Ursula Vehling-Kaiser, Tagesklinik Hämatologie Onkologie, Landshut; Lothar Kanz, University of Tübingen, Tübingen; Michael Pfreundschuh, Universitätsklinik des Saarlandes, Homburg; Wolfram Klapper, University of Kiel, Kiel, Germany; Françoise Berger, LYSA Group; Nicole Brousse, Hopital Necker; Catherine Thieblemont, Hôpital Saint Louis; Olivier Hermine, University Paris Descartes; Olivier Hermine, Université Sorbonne Paris Cité, Paris; Bertrand Coiffier, Centre Hospitalier Lyon-Sud, Pierre-Bénite; Réda Bouabdallah, Service d'Hématologie, Marseille; Vincent Ribrag, Institut Gustave Roussy, Villejuif, France; Stefano Pileri, University of Bologna, Bologna, Italy; Grzegorz Rymkiewicz, The Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland; Roman Kodet, Charles University, Prague, Czech Republic; and Johanna C. Kluin-Nelemans, University of Groningen, Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.8387DOI Listing
April 2016

Histone deacetylase inhibitor abexinostat affects chromatin organization and gene transcription in normal B cells and in mantle cell lymphoma.

Gene 2016 Apr 13;580(2):134-143. Epub 2016 Jan 13.

UMR 8126, Univ. Paris-Sud, CNRS, Institut de Cancérologie Gustave-Roussy, F-94805 Villejuif, France; LIA 1066 Laboratoire franco-russe de recherche en oncologie, F-94805 Villejuif, France; Koltzov Institute of Developmental Biology, Moscow, Russia. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03781119160006
Publisher Site
http://dx.doi.org/10.1016/j.gene.2016.01.017DOI Listing
April 2016

[Burkitt lymphoma, a diagnostic emergency]

Rev Prat 2016 01;66(1):79-82

Service d'hématologie, département de médecine.

View Article

Download full-text PDF

Source
January 2016

Novel targeted therapeutics for mantle cell lymphoma--what's on the horizon?

Expert Rev Hematol 2016 Mar 18;9(3):271-81. Epub 2016 Jan 18.

a Service d'hématologie, Département de Médecine , Institut Gustave Roussy , Villejuif , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17474086.2016.1134309DOI Listing
March 2016

Investigational drugs for T-cell lymphoma.

Expert Opin Investig Drugs 2016 17;25(2):171-81. Epub 2015 Dec 17.

a Service d'Hématologie, Département de Médecine , Gustave Roussy Cancer Campus , Villejuif , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/13543784.2016.1121994DOI Listing
September 2016

Histone deacetylase inhibitors and epigenetic regulation in lymphoid malignancies.

Invest New Drugs 2015 Dec 30;33(6):1280-91. Epub 2015 Sep 30.

UMR 8126 CNRS, Univ Paris-Sud, Université Paris-Saclay, Institut Gustave Roussy, 94805, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-015-0290-yDOI Listing
December 2015

Prognosis and outcome of stem cell transplantation for mantle cell lymphoma.

Expert Rev Hematol 2015 Aug 19;8(4):493-504. Epub 2015 Jun 19.

Hematology Department, Necker Hospital, Paris Descartes - Sorbonne Paris Cité University, INSERM U1163 CNRS ERL8654, Imagine Institute, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17474086.2015.1047759DOI Listing
August 2015

High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma.

Blood 2015 Jul 28;126(5):604-11. Epub 2015 May 28.

Department of Internal Medicine III, University Hospital Munich, Munich, Germany; Department of Medical Informatics, Biometry, and Epidemiology, University of Munich, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-02-628792DOI Listing
July 2015

Single nucleotide polymorphisms in ABCB1 and CBR1 can predict toxicity to R-CHOP type regimens in patients with diffuse non-Hodgkin lymphoma.

Haematologica 2015 May 30;100(5):e204-6. Epub 2015 Jan 30.

Anticancer Antibody Team, INSERM U1052, CNRS UMR 5286, Cancer Research Center of Lyon, France Hospices Civils de Lyon, France ProfileXpert, Lyon, France Laboratory of Hematology, Hospices Civils de Lyon, Pierre-Bénite, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2014.120113DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4420233PMC
May 2015

Phase 1 study of the oral histone deacetylase inhibitor abexinostat in patients with Hodgkin lymphoma, non-Hodgkin lymphoma, or chronic lymphocytic leukaemia.

Invest New Drugs 2015 Apr 21;33(2):423-31. Epub 2015 Jan 21.

Centre Hospitalier Régional de Lille, Hôpital Claude Huriez, Service des maladies du sang, Groupe de Recherche sur les formes Injectables et les Technologies Associées (GRITA), Université de Lille, Lille, France,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-015-0206-xDOI Listing
April 2015

Role of FDG-PET in the implementation of involved-node radiation therapy for Hodgkin lymphoma patients.

Int J Radiat Oncol Biol Phys 2014 Aug 8;89(5):1047-1052. Epub 2014 Jul 8.

Department of Imaging, Institut Curie R. Huguenin Hospital, Saint-Cloud, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2014.04.026DOI Listing
August 2014

Bradykinin antagonists and thiazolidinone derivatives as new potential anti-cancer compounds.

Bioorg Med Chem 2014 Aug 30;22(15):3815-23. Epub 2014 Jun 30.

Department of Biosynthesis of Nucleic Acids, Institute of Molecular Biology and Genetics, National Academy of Science of Ukraine, 150 Zabolotnogo Str., Kyiv 03680, Ukraine.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmc.2014.06.046DOI Listing
August 2014

Confirmation of the mantle-cell lymphoma International Prognostic Index in randomized trials of the European Mantle-Cell Lymphoma Network.

J Clin Oncol 2014 May 31;32(13):1338-46. Epub 2014 Mar 31.

Eva Hoster, Roswitha Forstpointner, Wolfgang Hiddemann, Martin H. Dreyling, and Michael Unterhalt, University Hospital Munich; Eva Hoster, University of Munich, Munich; Wolfram Klapper, University of Kiel; Christiane Pott, University Hospital Schleswig-Holstein, Kiel; Michael Hallek, Universität Köln, Köln; Stephan Stilgenbauer, University of Ulm, Ulm, Germany; Olivier Hermine, University Paris Descartes and Université Sorbonne Paris Cité; Catherine Thieblemont, Hôpital Saint Louis, Paris; Vincent Ribrag, Institut Gustave Roussy, Villejuif, France; Hanneke C. Kluin-Nelemans, University of Groningen, Groningen; Jeanette Doorduijn, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Jan Walewski and Michal Szymczyk, Maria Sklodowska-Curie Memorial Institute, Warsaw, Poland; Achiel van Hoof, A. Z. Sint Jan AV, Brugge, Belgium; Marek Trneny, Charles University General Hospital, Prague, Czech Republic; Christian H. Geisler, Rigshospitalet, Copenhagen, Denmark; and Francesco Di Raimondo, University of Catania, Italy.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2014/03/28/JCO.2013.52
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2013.52.2466
Publisher Site
http://dx.doi.org/10.1200/JCO.2013.52.2466DOI Listing
May 2014

Perinucleolar relocalization and nucleolin as crucial events in the transcriptional activation of key genes in mantle cell lymphoma.

Blood 2014 Mar 22;123(13):2044-53. Epub 2014 Jan 22.

Unité Mixte de Recherche 8126, Université Paris-Sud, National Centre for Scientific Research, Institut de Cancérologie Gustave Roussy, Villejuif, France;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2013-06-510511DOI Listing
March 2014

A dose-escalation study of SAR3419, an anti-CD19 antibody maytansinoid conjugate, administered by intravenous infusion once weekly in patients with relapsed/refractory B-cell non-Hodgkin lymphoma.

Clin Cancer Res 2014 Jan 16;20(1):213-20. Epub 2013 Oct 16.

Authors' Affiliations: Institut Gustave Roussy, Villejuif; Centre Hospitalier Universitaire Henri Mondor-Chenevier, Creteil; Centre Henri Becquerel, Rouen; Centre Hospitalier Universitaire de Lille, Lille; Centre Hospitalier Universitaire Pontchaillou, Rennes; Sanofi, Paris; Hospices Civils de Lyon and Université Lyon-1, Lyon, France; and ImmunoGen, Inc., Waltham, Massachusetts.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/content/20/1/213.full.
Web Search
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-13-0580DOI Listing
January 2014

Myeloid sarcoma of the nasopharynx mimicking an aggressive lymphoma.

Head Neck Pathol 2014 Jun 8;8(2):234-8. Epub 2013 Oct 8.

Clinical Haematology Department, Institut Gustave Roussy (IGR), 114 rue Edouard Vaillant, 94805, Villejuif, France,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12105-013-0495-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022928PMC
June 2014